Mori, Ryobu <br/><br/>
Bevacizumab for ramucirumab refractory malignant pleural effusion in non-small cell lung cancer: a case report and review of the literature.  [electronic resource] 

 -  Oncotarget  Jul 2017 
 - 48521-48524 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Review 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.17952  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Bevacizumab--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--diagnostic imaging<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Lung Neoplasms--diagnostic imaging<br/>Male<br/>Pleural Effusion, Malignant--pathology<br/>Tomography, X-Ray Computed<br/>Treatment Outcome<br/>Ramucirumab